Abstract
Chromatin conformation reorganization is emerging as an important layer of regulation for gene expression and lineage specification. Yet, how lineage-specific transcription factors contribute to the establishment of cell type-specific 3D chromatin architecture in the immune cells remains unclear, especially for the late stages of T cell subset differentiation and maturation. Regulatory T cells (Treg) are mainly generated in the thymus as a subpopulation of T cells specializing in suppressing excessive immune responses. Here, by comprehensively mapping 3D chromatin organization during Treg cell differentiation, we show that Treg-specific chromatin structures were progressively established during its lineage specification, and highly associated with Treg signature gene expression. Additionally, the binding sites of Foxp3, a Treg lineage specifying transcription factor, were highly enriched at Treg-specific chromatin loop anchors. Further comparison of the chromatin interactions between wide-type Tregs versus Treg cells from Foxp3 knock-in/knockout or newly-generated Foxp3 domain-swap mutant mouse revealed that Foxp3 was essential for the establishment of Treg-specific 3D chromatin architecture, although it was not dependent on the formation of the Foxp3 domain-swapped dimer. These results highlighted an underappreciated role of Foxp3 in modulating Treg-specific 3D chromatin structure formation.
Subject terms: T cells, Epigenetics in immune cells
Cell lineage specification involves substantial chromatin conformation reorganization. Here, the authors integrate in-situ Hi-C and PLAC-seq to map the dynamic changes in 3D chromatin structure during Treg cell differentiation. Furthermore, the authors further characterize the role of Foxp3 in the establishment of Treg-specific chromatin interactions by different Foxp3-mutant mouse lines.
Introduction
Genome-wide 3D chromosome conformation capture technologies have revealed that higher-order 3D chromatin structures of mammalian genome are hierarchically organized into chromosome territories, A/B compartments, topologically associating domains (TADs), and chromatin loops1–5. TADs are genomic regions that self-interact but insulate regions outside the domain, therefore contributing to the regulation of gene expression by restricting interactions of cis-regulatory elements to their target genes6–8. The zinc-finger transcription factor (TF) CTCF and the ring-shaped cohesin complex play critical roles in the formation and maintenance of TADs across different cell lineages9. However, these ubiquitously expressed proteins alone cannot establish and maintain cell lineage-specific genome architecture. Lineage-specific TFs have been proposed to regulate genome organization in specific cell lineages8,10,11. As for T cells in the immune system, it has been revealed that Bcl11b and TCF1 controls 3D chromatin architectures during early T cell development12–14. However, little is known about global genome organization for the late stage of T cell development and differentiation.
T cell development in the thymus occurs through several stages distinguished by the expression of cell surface markers CD4 and CD8. Early T cell precursors are CD4/CD8 double-negative (DN), which differentiate into the CD4/CD8 double-positive (DP) intermediate population, and then the mature CD4 single-positive (SP) or CD8 SP populations12,15 (Fig. 1a). Regulatory T cells (Treg) are derived in the thymus from CD4 SP cells, through two distinct developmental programs involving either CD25+Foxp3- or CD25-Foxp3+ Treg cell precursors, both of which develop into CD25+Foxp3+ mature Treg cells to maintain immune tolerance and homeostasis16–18. Treg cell lineage specification represents one of the final stages of T cell development and thus is an excellent model to examine the roles of lineage-specific TFs in 3D genome organization18,19. Foxp3, an X chromosome-encoded gene in the forkhead TF family, plays a central role in Treg cell lineage specification, phenotypic stability, metabolic fitness, and regulatory function20–27. Depending on the activating or repressing cofactors it associates with24,28, Foxp3 can either promote or inhibit target gene expression by exploiting pre-existing enhancer landscapes29. A recent study using HiChIP showed that Foxp3 was associated with enhancer-promoter loops to fine tune Foxp3-dependent gene expression30. However, it remains elusive how the Treg 3D chromatin architecture is established during their lineage specification, how it influences gene expression in Tregs, and whether and how Foxp3 contributes to Treg-specific chromatin interactions. Considering it was reported that Foxp3 has the capability to bring two distal DNA elements together through the formation a domain-swapped dimer31, it would be of great interest to test whether that Foxp3 can function as a loop anchor protein to directly contribute to the establishment of Treg-specific TADs and chromatin loops.
Here, we comprehensively mapped the chromatin interactions across different Treg developmental stages in the thymus, and Treg and Tcon cells in the spleen by in situ Hi-C. Our findings revealed that the 3D genome of Treg cells is gradually established during Treg cell development, and Treg-specific chromatin interactions were associated with Treg signature gene expression. Furthermore, through comparison of WT Treg cells with “wannabe” Treg cells (isolated from Foxp3-GFP knock-in/knockout mouse), and Foxp3 domain-swap mutant (DSM) Treg cells (isolated from a newly-generated Foxp3 DSM mouse strain), our data showed that Foxp3 was critical for the establishment of Treg-specific chromatin interactions, although not likely dependent on the Foxp3 domain-swapped dimer to form Foxp3-associated chromatin loops. Our results revealed a previously unappreciated aspect of Foxp3 function in the regulation of Treg cell development and function.
Results
Global transformation of 3D genome architecture during Treg lineage specification
To map the trajectory of the 3D genome organization during Treg lineage development, we performed in situ Hi-C experiments with T cells in different developmental stages, including CD4–CD8– (DN), CD4+CD8+ (DP), CD4–CD8+ (CD8SP), CD4+CD8–Foxp3-CD25- (CD4SP), CD4+CD8–Foxp3–CD25+ (CD25+ Treg precursor), CD4+CD8–Foxp3loCD25– (Foxp3lo Treg precursor), CD4+CD8–Foxp3+CD25+ (Treg) from the thymus, and CD4+Foxp3– (conventional T cells, Tcon) and CD4+Foxp3+ (mature Treg) from the spleen (Fig. 1a, Supplementary Fig. 1a, 1b, and Supplementary Data 1). In situ Hi-C is a genome-wide variant of chromatin conformation assay that provides an all-to-all, high resolution view of chromatin interactions in the genome2. Chromatin interaction maps were constructed from in situ Hi-C data at different resolutions down to 2 kb resolution (Fig. 1b). To examine patterns of gains and losses of chromatin interactions, we performed K-means clustering on normalized Hi-C contacts across each T cell population at 100 kb resolution (Fig. 1c). This revealed evidence for both gains and losses of chromatin interactions throughout the T cell developmental trajectory (Fig. 1c, d). We next use T-distributed Stochastic Neighbor Embedding (t-SNE) map to visualize and compare different T cell subsets in two dimensions. t-SNE showed tight grouping between replicate experiments from the same T cell subset, indicating high reproducibility of the chromatin contact maps. Furthermore, the t-SNE map clearly showed a differentiation trajectory of Treg cell development in the thymus, in parallel to the trajectory generated based on gene expression profile of each T cell subset (Fig. 1e). Therefore, the 3D genome structure is being reorganized following the differential steps of thymic Treg cell development.
Treg-specific chromatin contacts are associated with Treg gene expression and selective transcription factor binding activities
To examine whether Treg cells have a unique 3D chromatin structure to support their distinct gene expression profile and function, we performed a pairwise comparison of the 3D chromatin structure of splenic Treg and Tcon cells. Using edgeR to detect differential chromatin contacts at 25 kB resolution, we identified 1959 upregulated DNA interactions in Treg cells and 1973 upregulated DNA interactions in Tcon cells (FDR 1%, Fig. 2a, Supplementary Data 2). As an example, we observed strong DNA interactions close to the Socs2 gene locus in Treg cells, but not in conventional T cells (Fig. 2b). The Hi-C data showed that a vast majority of DNA interactions were similar between Treg and Tcon, with only 0.29% of tested chromatin interactions showing a significant change between Treg and Tcon cells (3932/1377570). This small percentage agreed with previous studies showing that less than 5% of the genes are differentially expressed in these two T cell populations22,32,33. Additionally, Treg and Tcon cells share 99% of their enhancers, less than 1% of the enhancers are unique to either T cell population29. In examining the changes in Treg and Tcon specific chromatin interactions during Treg lineage commitment, we observe that Treg specific interactions most dramatically differ upon expression of Foxp3 and some are further strengthened in Foxp3+ CD25+ cells (Supplementary Fig. 1c). In contrast, most Tcon specific interactions are lost upon expression of Foxp3 and do not show further reductions in Foxp3+ CD25+ cells (Supplementary Fig. 1c), suggesting that Foxp3 expression is the major distinguishing characteristic of when Treg versus Tcon specific chromatin interactions emerge.
We next examined whether the differences in 3D chromatin structures between Treg and Tcon cells are associated with changes in gene expression. Analysis of gene expression profiles of Treg and Tcon cells revealed that 928 genes (FDR < 1% and Fold change >2) were differentially expressed (Fig. 2c). Based on Hi-C data, of the 3932 differential chromatin interactions between Treg and Tcon cells, 617 chromatin interaction anchors overlapped with the transcription start site of at least one gene. Strikingly, differentially expressed genes were strongly enriched at differential chromatin interactions, with Treg specific genes enriched at Treg specific chromatin interactions, and Tcon specific genes enriched at Tcon specific chromatin interactions (Fig. 2d). This result suggested that differences in gene expression are potentially associated with unique DNA interacting activities in Treg cells.
To further explore the link between chromatin interactions and gene expression, we determined the number of differential interacting partners for each individual interaction anchor that is proximal to a differentially expressed gene. While most loci with differential interactions had only one partner anchor, a minority of loci form multiple differential long-range contacts (Fig. 2e). We observed that the loci with higher numbers of differential long-range interactions were more likely to be associated with differentially expressed genes (Fig. 2f, g). Of note, the loci with more than four differential DNA interactions were associated with several well-established Treg signature genes, including Ikzf2, Lrrc32 (encoding GARP), Socs2, and Ptger4 (Fig. 2g, h). These results further illustrated the correlation between changes in DNA interactions and differential gene expression in Treg cells.
To search for factors involved in establishing a Treg-specific 3D chromatin structure, we compared the relative enrichment of several TFs and chromatin structure regulators in Treg- and Tcon- specific loop anchors. Although CTCF and cohesin are critical for the formation of DNA loops34,35, their relative enrichments in Tcon or Treg-specific loop anchors were moderate (Fig. 2i). In contrast, multiple TFs, including Foxp3, Satb1, Runx1, Ets1, and Bcl11b, which are involved in Treg differentiation and function, showed a more pronounced enrichment in Tcon or Treg-specific interactions. Strikingly, the enrichment of Foxp3 bound peaks was ranked first among all the TFs tested, suggesting that Foxp3 might play a crucial role in Treg-specific loop formation (Fig. 2i).
Foxp3 is critical for the establishment of Treg-specific 3D chromatin structure
Foxp3 is a pivotal regulator of Treg differentiation and function. Given that Foxp3 bound peaks are highly enriched in the anchor regions of Treg-specific chromatin interactions, we examined Foxp3’s role in the formation and maintenance of Treg-specific DNA loops. To this end, we used a GFP knock-in Foxp3 knockout mouse strain (Foxp3GFP-KIKO)33, in which GFP expression replaces Foxp3 and can be used as a fluorescent marker to identify Treg “wannabe” cells (Fig. 3a). As reported previously, Treg “wannabe” cells receive similar TCR signals and developmental cues like WT Tregs, express the majority of Treg signature genes, and might represent Treg precursors, as reflected by mRNA transcriptional activity at the Foxp3 locus but lack Foxp3 protein expression and suppressive function29,33. Hi-C experiments were performed with GFP+Foxp3– Treg- “wannabe” cells from healthy heterozygous female Foxp3GFP-KIKO/WT mice and control GFP+Foxp3+ WT Treg cells from Foxp3GFP/WT mice. We focused on chromatin contacts that were Treg specific in our comparison of Treg and Tcon chromatin interactions. Comparison between the chromatin contacts in GFP+Foxp3+ WT Treg cells and GFP+Foxp3– Treg “wannabe” cells showed that a total of 94 out of 1959 Treg-specific interactions were significantly reduced in the GFP+ Foxp3-KIKO cells (Fig. 3b, FDR = 10%). While this represents a minority of the Treg-specific contacts (4.8% or 94/1959), the decrease in Treg-specific DNA contacts in Foxp3 KIKO cells was also illustrated by the overall distributions of KIKO vs. WT contact frequency fold-changes (Fig. 3c). Specifically, 76.3% (1495/1959) of Treg-specific contacts showed a decrease (fold change <0) in chromatin interaction frequency in GFP+ Foxp3-KIKO cells relative to control GFP+Foxp3+ WT Treg cells. Similarly, Tcon-specific chromatin interactions were globally upregulated in Foxp3 KIKO cells compared to WT Tregs (Fig. 3c). We performed RNA-seq to identify genes that change expression between Foxp3-KIKO and WT Tregs. We identified 566 differentially expressed genes between Foxp3-KIKO and WT Tregs (FDR < 5%, fold-change >2) (Supplementary Data 3). Of these differentially expressed genes, these were strongly enriched for overlapping with sites of differential chromatin interactions between Treg and Tcon cells or between Foxp3-KIKO and WT Tregs (Fig. 3d), suggesting that the change in chromatin interactions between Foxp3-KIKO and WT Tregs likely contributes to altered patterns of expression in a Foxp3 dependent manner.
The reduction of chromatin interactions in GFP+Foxp3– Treg- “wannabe” cells could be seen at the locus of the Ikzf2 gene, one of the Treg signature genes that was significantly downregulated in Foxp3-KIKO Tregs. In Tcon cells, there were no detectable chromatin interactions around Ikzf2, while strong DNA interacting loops emerged in WT Treg cells. In the Treg- “wannabe” cells, the chromatin interactions were significantly weakened at the Ikzf2 locus (Fig. 3e). ChIP-seq and Cut&Run experiments showed the DNA looping anchors around Ikzf2 were enriched with Foxp3 bound peaks along with CTCF and cohesin component Smc1a bound peaks (Fig. 3f). The fact that some but not all Treg specific chromatin interactions lost in GFP+Foxp3– Treg- “wannabe” cells led us to investigate whether contacts lost in GFP+Foxp3– Treg- “wannabe” cells may be more dependent on Foxp3. Indeed, chromatin contacts that were lost in the Treg- “wannabe” cells compared to controls were more likely to contain Foxp3 binding peaks (Fig. 3g). In addition to Foxp3 binding sites, we also examined the enrichment of TF motifs in Treg DNase I Hypersensitive Sites (DHS) and identified motifs with differential TF motif enrichment in chromatin contacts lost versus retained in GFP+Foxp3– Treg- “wannabe” cells versus control cells (Fig. 3h). Specifically, we saw modest enrichments of CTCF and ETS-family TF motifs in DHS sites at chromatin contacts retained in GFP+Foxp3– Treg- “wannabe” cells, whereas we saw enrichment of AP-1 and Forkhead motifs in the chromatin contacts lost in the GFP+Foxp3– Treg- “wannabe” cells. This suggests that these TFs, in conjunction with Foxp3, may be critical for the establishment of the mature Treg 3D chromatin landscape. Taken together, these data suggest that the establishment of Treg-specific chromatin interactions is dependent on Foxp3 expression.
Mutations in the Foxp3 domain-swapped dimerization interface lead to inadvertent immune system activation in mice
Although our data clearly indicated that Foxp3 is indispensable for establishing Treg-specific 3D chromatin structure, it is not clear whether Foxp3 is directly involved in DNA looping like CTCF/cohesin, or whether it acts indirectly as a factor that facilitates the binding of architectural proteins including CTCF and cohesin to form Treg-specific chromatin interactions. It was reported that Foxp3 is able to form a domain-swap (DS) dimer through its forkhead domain to bring two distal DNA elements together31, suggesting Foxp3 has the potential to facilitate DNA looping directly (Fig. 4a). Of note, three amino acid mutations (W348Q, M370T and A372P) in the DS interface that disrupt DS dimer formation diminish Treg suppressive activity without compromising Foxp3 DNA binding in vitro, indicative of a direct role of Foxp3 in regulating Treg function by modulating Treg cell 3-D chromatin structure31. To test this possibility, we generated a Foxp3 DSM mouse strain by using CRISPR technology to introduce the above mutations (W348Q, M370T and A372P) into the Foxp3 coding region in the Foxp3-IRES-Thy1.1 reporter mouse (Fig. 4b). After verifying the mutations by DNA sequencing, we analyzed Foxp3 DSM mice and WT littermate controls to determine whether disabling Foxp3’s domain swapped dimerization affects Treg cell development and function. The Foxp3 DSM mice appeared to be normal up to 2 months of age when they started to develop a moderate lymphoproliferative disease with loss of body weight and increased cellularity in the spleen (Fig. 4c, d). The frequency of Treg cells was higher while Foxp3 protein level was significantly reduced in Foxp3 DSM mice compared to WT controls (Fig. 4e). CD4+ conventional T cells and CD8+ T cells were also more activated with the expansion of the CD44+CD62Llow population. (Fig. 4f). Consistently, IFNγ production increased significantly in splenic CD4+ T cells from Foxp3 DSM mouse (Fig. 4g). Furthermore, serum concentrations of IgG1 and IgM were significantly higher in Foxp3 DSM mice compared to WT controls (Fig. 4h). Histopathology analysis of 6- to 9-month-old Foxp3 DSM mice revealed widespread immune cell infiltration in the lung, liver, small intestine, and salivary gland tissues (Fig. 4i). Taken together, these data suggested that the inability of Foxp3 to dimerize in “trans” leads to a moderate defect in Treg cell’s immune suppressive function which results in excessive immune system activation.
The formation of Treg-specific chromatin interactions is independent of Foxp3 domain-swap dimerization
Next, we sought to assess whether the impairment of Foxp3 DSM Treg function was because DS mutation disrupted the formation of Treg 3D genome structure, and subsequently affected Treg signature gene expression. To this end, we isolated Treg cells from 6-week-old asymptomatic Foxp3 DSM and control mice and performed in-situ Hi-C experiments to map their 3-D genome structure. Foxp3 DSM and WT Treg cells showed similar chromatin interaction patterns as a whole and within Treg-specific interactions (Fig. 5a). In fact, none of the 1959 Treg specific chromatin interactions is significantly different in the DSM Tregs compared to the WT Tregs (FDR < 10%) (Fig. 5b). Furthermore, we did not observe a global loss of chromatin contacts at Treg-specific interactions in the DSM Treg cells as we do in the GFP+ Foxp3 KIKO cells (Fig. 5c). Finally, the lack of differences in 3D structure between DSM and WT Tregs was not related to statistical power or data quality, as the sequencing depth and Hi-C library quality was comparable between Tcon, Treg, KIKO, and DSM experiments (Supplementary Data 1). Taken together, these results show that domain-swapped dimerization of Foxp3 is not required for establishing Treg-specific 3-D genome structure.
To further dissect the molecular mechanism underlying DSM Treg’s impaired function, we performed RNA-seq experiments with DSM and WT Treg cells. There were 26 up-regulated genes and 121 down-regulated genes in DSM Tregs compared to WT Tregs (Fig. 5d, FDR 5%, greater than 2-fold change, Supplementary Data 4). Interestingly, the differentially expressed genes in the DSM Treg cells showed expression patterns resembling Tcon cells, rather than WT Treg cells (Fig. 5e), suggesting that the DS mutation disrupts Foxp3’s transcriptional regulation function. The expression of several Treg signature genes, Lrrc32 (encodes the GARP protein), Tigit, and Ctla4, were compromised in DSM Tregs, contributing to their impaired immune suppressive function.
To further explore the mechanism underlying dysregulated gene expression in DSM Tregs despite the lack of changes in 3D genome structure, we examined whether the DSM mutation contributed to differences in Foxp3 binding using CUT&RUN. We identified 36,727 Foxp3 binding peaks in WT and DSM Tregs by CUT&RUN. Comparing peak strength between WT and DSM-mutant Tregs, we identified 295 peaks that showed differential Foxp3 binding (Fig. 5f, FDR 5%, Supplementary Data 5). We then analyzed differential Foxp3 binding peaks based on their distance to differentially expressed genes (DEGs) in WT and DSM Tregs. The differential DSM Foxp3 binding peaks were significantly closer to DEGs compared to non-affect Foxp3 binding peak controls (Fig. 5g). For example, although chromatin interactions around Lrrc32 were similar, the main Foxp3-bound peak was weaker in DSM Tregs compared to WT controls (Fig. 5h, i). It is likely that defective Foxp3 binding resulted in the reduced expression level of Lrcc32 in DSM Tregs (Fig. 5j). Taken together, these results suggest that the domain-swapped mutation negatively affects Foxp3 binding to the loci of a subset of genes, leading to compromised gene expression and defective Treg function.
Foxp3-associated chromatin interactions are functionally required for Treg cell function
To further understand how Foxp3 is involved in the establishment of Treg-specific chromatin interactions, we performed proximity ligation-assisted ChIP-seq (PLAC-seq)36 with an antibody against Foxp3 in Treg cells. PLAC-seq is an assay that combines Hi-C experiments with ChIP, such that chromatin interactions associated with a factor of interest can be studied in higher resolution. This enabled us to analyze Foxp3-associated chromatin interactions with higher sensitivity and efficiency. Using Foxp3 PLAC-seq data, we identified 1165 focal loops at 10 kB resolution (Supplementary Data 6). These focal loops were highly overlapped with Foxp3 binding peaks in Treg cells (Fig. 6a). In total, we identified 2169 Foxp3-associated loop anchors, of which the majority contained a Foxp3 binding site or had a Foxp3 binding site within 10 kB (Fig. 6b). Of note, 9.01% of the total Foxp3 binding sites are associated with chromatin interactions identified by Foxp3 PLAC-seq (Fig. 6c). We next classified Foxp3-associated DNA loops based on the locations of the loop anchors relative to genes. More than two-thirds of the loops are gene-gene (22.49% vs. expected 4.35%), gene-enhancer (27.12% vs expected 2.61%), enhancer-enhancer (17.17% vs. expected 1.14%) interactions, implicating their involvement in the regulation of gene expression (Fig. 6d).
To examine how Foxp3-associated chromatin interactions influence gene expression, we compared the expression of genes whose transcription starting site overlaps with Foxp3 PLAC-seq interactions between CD4+ conventional T cells and Tregs. A number of Treg signature genes, including Ikzf2, Icos, Entpd1, and Il7r, emerged as associated with Foxp3 PLAC-seq interactions (Fig. 6e). We next directly tested whether Foxp3-associated chromatin loops facilitate gene expression at the Ikzf2 locus. Using a pair-guide RNA mediated CRISPR/Cas9 approach37, we systemically deleted 9 Foxp3 binding sites (named P1 to P9) located close to the Ikzf2 gene, and measured Helios protein (encoded by the Ikzf2 gene) expression in Treg cells compared to cells transduced with non-targeting sgRNAs (Fig. 6f and Supplementary Fig. 2). When the Foxp3 binding site at the P1 or P6 regions were deleted, Helios expression decreased significantly (Fig. 6g). The P6 region is located in the Ikzf2 promoter, therefore its deletion served as a positive control. We next deleted the P1 or P6 region in mature splenic Treg cells in vitro, which were then transferred into Rag1 knockout recipient mice to track deletion’s impact on Tregs in vivo. Indeed, Helios expression was reduced in Tregs isolated from P1 deleted Treg cells (Fig. 6h), suggesting that the P1 region is a Foxp3 bound enhancer. Interestingly, Hi-C analysis showed that P1 deletion did not significantly weaken Foxp3 PLAC-seq peak at the Ikzf2 locus (Fig. 6i). This data suggests that Foxp3 may not be required for the maintenance of Treg-specific chromatin interactions, despite that Foxp3 binding is essential for Ikzf2 expression.
To further characterize Foxp3’s role in the maintenance of Treg-specific chromatin interactions in mature Treg cells, we used CRISPR/Cas9 to knockout Foxp3 in splenic Treg cells in vitro and profiled their 3D genome structure by in situ Hi-C (Supplementary Fig. 3a, b). Unlike GFP+Foxp3– KIKO cells, the deletion of Foxp3 by sgRNA in mature Treg cells did not change their chromatin interaction patterns as a whole or within Treg-specific interactions (Supplementary Fig. 3c). There was no global loss of chromatin contacts at Treg-specific interactions in the sgFoxp3 Treg cells as in the GFP+ Foxp3– KIKO cells (Supplementary Fig. 3d). Therefore, Foxp3 is essential for establishing Treg-specific chromatin interactions but dispensable for the maintenance of these interactions in mature Treg cells.
Our results comparing Foxp3-KIKO vs. WT Treg cells suggest that Foxp3 is critical for the establishment of Treg-specific chromatin interactions. In addition, chromatin interactions that are lost in Foxp3-KIKO cells show different motif enrichment patterns compared with chromatin interactions that are retained (Fig. 3h). This raises the possibility that Foxp3 may control a subset of chromatin interactions, and therefore genes, during Treg lineage commitment. To further investigate Foxp3’s role in Treg gene expression, we compared Treg-specific genes, which are differentially expressed between Treg and Tcon cells, with genes that are dysregulated in either the KIKO or DSM Treg cells. This divided the Treg-specific genes into two sets, “Foxp3 dependent” (changing in KIKO or DSM or both) and Foxp3 independent (not changing in KIKO or DSM) (Fig. 7a, Supplementary Data 6). Gene Ontology (GO) analysis of these two sets of genes revealed distinct GO terms. For the Foxp3-dependent genes, the top terms were related to immune function, cytokines, and cell adhesion (Fig. 7b). For the Foxp3 independent genes, the top hits were related to metabolism and cell cycle (Fig. 7c). This was not caused by a specific p-value threshold, because by comparing the GO terms obs/exp gene sets, there were a large number of GO terms that were specific to the Foxp3 dependent or independent set (Fig. 7d). Furthermore, about 3/4 of all the GO terms that came up as significant in either the Foxp3 dependent or independent sets are specific to each set (Fig. 7e). These analyses suggested that Foxp3 regulates genes related to the immune function of Treg cells, while other factors regulate cell cycle and cell metabolic processes during Treg lineage commitment.
Discussion
In this study, we examined the role of Treg lineage-specific TF Foxp3 in 3D genome organization during the late stage of T cell development. We compared the 3D chromatin structures of Treg cells and their precursors and revealed that the 3D chromatin architecture of Treg cells was gradually established during Treg lineage specification, and that changes in chromatin interactions align with the trajectory of Treg development. By comparing Treg cells and their closely related conventional T cells, we identified chromatin structures unique to Treg cells. Overall, the Treg’s chromatin structure was highly similar to that of conventional T cells, 0.29% (3932/1377570) chromatin interactions were significantly different between Treg and Tcon cells. This small number of differential chromatin interactions are in line with less than 1% of differential enhancers, and less than 5% of differentially expressed genes between Treg and conventional T cells. Strikingly, these Treg-specific chromatin interactions were frequently associated with the loci of Treg signature genes.
Our study investigated Foxp3’s contribution to the establishment and maintenance of Treg chromatin structure. Notably, Foxp3 was significantly enriched at the anchor regions of Treg-specific chromatin loops, even ranking higher than CTCF/cohesin. By taking advantage of Treg-“wannabe” cells from Foxp3GFP-KIKO mice, our data revealed that Foxp3 was essential for the establishment of Treg-specific chromatin structure, which agreed with a recently published Foxp3 HiChIP study30. It was proposed that the domain-swapped dimer of Foxp3 facilitates its potential role as a DNA loop anchor to establish Treg-specific chromatin interactions31. We further examined whether Foxp3 can function as a DNA loop anchor by comparing of WT and DSM Treg cells. Although the Foxp3 DSM Treg cells were dysfunctional and the Foxp3 DSM mice developed lymphoproliferative disease, the 3D chromatin architecture of the Treg cells was not affected by mutations disrupting Foxp3 domain-swapped dimerization. Instead, the defective function of DSM Tregs is likely caused by impaired Foxp3 binding to key Treg gene loci. Furthermore, a recent study showed that the Foxp3 domain-swapped dimer is dysfunctional, while a head-to-head dimer represents the physiological form of Foxp338. Altogether, these data suggested that domain-swapped dimerization of Foxp3 is not required for the organization of Treg’s 3D chromatin structure.
The Foxp3 PLAC-seq and Foxp3 ChIP-seq/CUT&RUN data also revealed that Foxp3-associated chromatin interactions were associated with the loci of Treg-signature genes, including Ikzf2, Icos, Entpd1, and Il7r. Although the deletion of Foxp3 binding sites in the Ikzf2 locus decreased its expression, it did not disrupt the chromatin interactions at the corresponding regions. Furthermore, the ablation of Foxp3 in mature Treg cells did not alter their 3D genome structure. This data indicates that although Foxp3 plays an essential role in the formation of Treg-specific chromatin interactions, it has only marginal effects on the maintenance of their 3D chromatin structure. Furthermore, by comparing WT Treg, “wannabe” Treg, and DSM Treg gene expression, we found that Treg-characteristic genes can be separated into Foxp3-dependent and Foxp3-independent groups, with Foxp3-dependent genes enriched in Treg immune suppressive functions, while Foxp3-independent genes enriched in metabolic and cell cycle regulations.
In summary, our data suggest that Foxp3 as a Treg lineage-specific TF facilitates chromatin structure reorganization to establish Treg’s cell identify. Since Foxp3 by itself does not function as a chromatin loop anchor to stabilize chromatin interactions, it likely cooperates with other proteins such as CTCF, cohesin, and YY139 to set up Treg-specific 3D genome structure during Treg development. Once the 3D genome structure is formed in mature Tregs, the contribution of Foxp3 in the maintenance of Treg 3D chromatin structure seems to be relatively minor. Instead, Foxp3 acts as a TF to activate or repress gene expression by leveraging the promoter-enhancer proximity facilitated by the Treg-specific chromatin looping structure. This study presented a model of how lineage-specific TFs function during the late or terminal stage of cell differentiation.
Methods
Mice
All mice were housed in a specific pathogen-free facility under a 12 h light/dark cycle, with an ambient temperature of 20–26 °C and humidity of 30–70% at the Salk Institute. Animal experiments were performed under the regulation of the Institutional Animal Care and Use Committee according to the institutional guidelines. All mice used in the present study are in the C57BL/6 genetic background. Rag1–/– mice purchased from the Jackson Laboratory were used for adoptive Treg cell transfer. Foxp3Thy1.1 reporter mice40, Foxp3GFP reporter mice22, and Foxp3GFPKO mice33 were used to isolate T cell populations from the thymus and Tcon and Treg cells from spleen for in-situ Hi-C, PLAC-seq, CUT&RUN, and RNA-seq experiments. Rosa-Cas9/Foxp3Thy1.1 mice41 were used to isolate Treg cells for CRISPR validation of the effect of Foxp3-binding sites on Helios expression.
Generation of Foxp3 domain-swap mutant knock-in mice
The Foxp3 DSM mice were generated by CRISPR/Cas9-based genome editing42. Briefly, two sgRNAs containing the target sequences gRNA1(TGAAAGGGGGTCGCATATTG) and gRNA2 (AAACCACCCCGCCACCTGGA) and Cas9 protein were used to introduce double-strand DNA breaks; a 1340 base pair (bp) single-strand DNA (ssDNA) containing the sequence encoding the three amino acids mutations (W348Q, M370T, A372P) was used to introduce Foxp3 DS mutations via homology-directed DNA repair mechanism. The gRNAs-Cas9 RNP together with ssDNA were injected into fertilized eggs derived from the Foxp3Thy1.1 reporter mice, and then transplanted into pseudo-prepregnant recipient mice. The genomic region surrounding the target sites was amplified from genomic DNA of resultant founder progeny by PCR using the following primers: 5’-TCTGAGGAGCCCCAAGATGT-3’, 5’-CCACTCGCACAAAGCACTTG-3’. After verifying the Foxp3 DS mutations by sequencing, Foxp3 DSM mice were bred with Foxp3Thy1.1 mice and analyzed to determine the outcomes of the Foxp3 DS mutation. Details of the ssDNA sequence are listed in Supplementary Table 1.
T cell isolation and analysis
DN, DP, CD8SP, CD4SP, CD25+ Treg precursor, Foxp3lo Treg precursor, thymic Treg cells were isolated by FACS sorting from a thymocyte suspension. Tcon and Treg cells were isolated from the spleen by pre-enrichment with EasySep Mouse CD4+ T cell Isolation Kit (STEMCELL Technologies, Cat# 19852), and FACS sorting. The individual cell population was sorted by FACS using the following markers. DN: CD45+CD4-CD8-; DP:CD45+CD4+CD8+; CD8SP: CD45+CD4-CD8+; CD4SP: CD45+CD4+CD8-CD25- Foxp3-reporter-; CD25+ Treg precursor: CD45.2+CD4+CD8-CD25+Foxp3-reporter-; Foxp3lo Treg precursor: CD45+CD4+CD8-CD25-Foxp3-reporterlow; mature thymic Treg: CD45+CD4+CD8-CD25+Foxp3-reporter+; splenic Tcon cells: CD45+TCRb+CD4+CD8-Foxp3-reporter-; splenic Treg cells: CD45+ TCRb+CD4+CD8-Foxp3-reporter (Thy1.1 or GFP)+.
To analyze immune cell compositions in Foxp3 DSM mice, a single cell suspension was prepared from the spleen or lymph nodes, treated with red cell lysis buffer, and filtered through 70 μm cell strainer. For TF staining, cells were first stained for surface markers, followed by fixation and permeabilization with reagents from the Foxp3/TF Staining Buffer Set (eBioscience, 00-5521-00) and incubated with antibodies according to the manufacturer’s protocol. For cytokine analysis, cells were stimulated with phorbol 12-myristate 13-acetate (PMA) (50 ng ml-1; Sigma), ionomycin (500 ng ml-1; Sigma) and GolgiStop (BD) for 5 h. Cells were incubated with cell surface antibodies on ice for 30 min, and then subjected to intracellular staining using Foxp3/TF Staining Buffer Set as described above. Samples were run on a BD FACSAria II Flow Cytometer (Becton Dickinson) and data were analyzed by FlowJo software (Tree Star). Details of antibodies, viability dye and dilutions are listed in Supplementary Table 2.
In situ Hi-C
In situ Hi-C experiments were performed as previously described2 using restriction enzyme MboI (NEB) with minor modifications. Briefly, 0.5 × 106 cells per each developmental stage from DN to mature thymic Treg cells, and 1 × 106 splenic Tcon and Treg cells were FACS-sorted and collected for individual biological replicates. Cells were resuspended in RMPI1640 medium at a concentration of 1 × 106 cells per mL, cross-linked with 1% formaldehyde for 10 min at room temperature with rotating, and subsequently lysed and digested with 100 Units of MboI/1 million cells at 37 °C for 2 h. The following steps including making of DNA ends, proximity ligation and crosslink reversal, DNA shearing and size selection, biotin pull-down and preparation for Illumine Sequencing, final amplification and purification were carried out as previously described.
CUT and RUN
CUT&RUN experiments were performed as previously described43 with minor modifications. To avoid the potential activation of T cells by Concanavalin-A (ConA) beads in the standard protocol, we instead used a spin-down method to collect cells as previously reported44. Briefly, 0.5 × 106 cells per biological replicate were collected in V-bottom 96-well plate. Cells were first washed twice in Antibody Buffer (2 mM EDTA, 1x EDTA-free protease inhibitors, 0.5 mM spermidine, 1x permeabilization buffer from eBioscience™ Foxp3/TF Staining Buffer Set) by centrifugation at 800 g for 6 min at 4 °C, and then incubated with normal IgG, H3K27ac antibody, or Foxp3 antibody41 on ice for 1 h. After two washes with buffer 1 (1x EDTA-free protease inhibitors, 0.5 mM spermidine, 1x permeabilization buffer), cell pellets were incubated with pA/G-MNase (20x) enzyme (EpiCypher) in 50 µl buffer 1 at 4 °C for 1 h. Cells were washed twice in saponin buffer (0.05% (w/v) saponin, 1x EDTA-free protease inhibitors, 0.5 mM spermidine in PBS) and resuspended in 100 µl calcium buffer (2 mM CaCl2 in buffer 2) on ice for 30 min. 100 µl 2x stop buffer (20 mM EDTA, 4 mM EGTA in saponin buffer) was then added and incubated at 37 °C for 10–20 min to release cleaved chromatin fragments. The supernatant containing chromatin fragments was collected by centrifugation and DNA was extracted using a QIAGEN MinElute kit according to manufacturer’s protocol.
The CUT&RUN libraries were prepared using the NEBNext® UltraTM II DNA Library Prep Kit for Illumina® (E7645) according to manufacturer’s instructions.
PLAC-seq
PLAC experiments were performed as previously described36. Briefly, 20 × 106 cells per biological replicate were crosslinked in 1% formaldehyde for 10 min at room temperature. After digestion with the restriction enzyme MboI, labeling DNA ends with biotin-14-dATP, and proximity ligation of DNA ends, the resultant chromatin was sonicated to 200–600 bp using a Covaris E229 sonicator for 10 min. Sonicated chromatin was pre-cleared with Protein A + G magnetic beads followed by overnight chromatin immunoprecipitations with 5 µg Foxp3 antibody41. Libraries were prepared using NuGen Ovation Ultralow Library System V2 kit according to the manufacturer’s instructions and sequenced by an Illumina HiSeq2500 sequencer.
RNA-seq
1 × 104 cells were FACS-sorted into TRIzol RNA isolation reagent (Invitrogen) and RNA was isolated according to the protocol. RNA concentration and integrity was determined by Bioanalyzer using RNA 6000 Pico Kit (Agilent). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit (Illumina) following manufacturer’s instructions.
Serum immunoglobulin ELISA
Serum IgG1, IgG2c, IgM, and IgA concentrations were measured by ELISA using the SBA Clono-typing System (Southern Biotech).
Histology
For histology analysis, lung, liver, small intestine, and salivary gland tissues were fixed in 10% neutral buffer formalin, paraffin-embedded, sectioned, and stained with hematoxylin and eosin by Pacific Pathology (San Diego, CA).
In vitro culture of Treg cells
Treg cells were isolated from spleen of the Foxp3Thy1.1 reporter mice by staining with PE-labeled Thy1.1 antibody followed by enrichment with Anti-PE magnetic beads (Miltenyi, Cat# 130-048-801). Purity of the Treg cells was confirmed to be over 95% by FACS. Treg cells were activated by plate-bound anti-CD3 and anti-CD28 antibodies in complete RPMI1640 medium containing 10% FBS, 100 U/ml Penicillin/Streptomycin, 1x GlutaMax, 1 mM HEPES, 1 mM sodium pyruvate, 1x NEAA, 55 mM 2-mercaptoethanol, 10 mg/ml gentamycin, and IL-2 at 500 U/ml.
CRISPR knockout of Foxp3 binding sites in Ikzf2 locus
Cloning of sgRNAs into the pSIRG-NGFR vector, and retrovirus production in HEK293T cells were performed as previously described45. Details of sgRNA sequence are listed in Supplementary Table 3.
To test the effects of Foxp3 binding sites on Helios expression in vitro, Treg cells isolated from Rosa-Cas9/Foxp3Thy1.1 mice were transduced with retrovirus carrying the sgRNAs targeting P1 region, P6 region, or control non-targeting sgRNAs. Cells were stained and analyzed for Helios expression by FACS 5 days after transduction.
In vivo adoptive Treg cell transfer
To test the effect of Foxp3 binding sites in the Ikzf2 locus on Helios expression in vivo, Treg cells from Rosa-Cas9 mice were first transduced with control sgRNAs, sgRNAs targeting P1 or P6 region on day 1, and then sorted by FACS on day 3 to enrich Treg cells transduced with sgRNAs (CD4+Foxp3Thy1.1+NGFR+). CD45.2+ Treg cells transduced with control sgRNAs were mixed with CD45.1+CD45.2+ Treg cells transduced with sgRNAs targeting P1 or P6 region respectively at a ratio of 50:50 into RAG1 KO mice. 2 weeks after transfer, T cells in the spleen were harvested for analysis of the expression of Helios.
In-situ Hi-C and PLAC-seq data analysis
Hi-C and PLAC-seq data were aligned to the mm9 reference genome using BWA-MEM46. Reads were filtered (MAPQ > = 30) and paired using a previously described pipeline47. PCR duplicate reads were removed using Picard. Contact matrices were generated and normalized using the iterative correction method48. Enriched contacts in the PLAC-seq data were identified using HICCUPs49.
To detect differential chromatin interactions between experiments, we calculated contact frequencies in 25 kb bins for all interactions genome wide separated by less than 1 Mb. Differential interacting regions were called using edgeR50 with Benjamini-Hochberg correction for multiple testing.
TF motif enrichment in Foxp3-dependent chromatin interaction sites was performed by first identifying differential chromatin interactions between wild-type (Foxp3GFP+ ) and Foxp3 knockout (KIKO GFP+ ) Tregs at a resolution of 25 kb. Differential interacting regions were overlapped with DHS in mouse Tregs from ENCODE (accession ENCFF566TDU). Motif enrichment over these DHS sites found in differential interaction regions was performed using Homer51 using the collection of known vertebrate motifs from the JASPAR database.
RNA-seq data analysis
RNA-seq data were aligned by using STAR46 to the mm9 reference genome. PCR duplicates were removed, and read counts were quantified over GENCODE genes (vM1) using HTSeq and subject to RPKM normalization. Differentially expressed genes were identified using edgeR50. GO analysis was performed using TopGO52.
CUT&RUN data analysis
CUT&RUN data was aligned to the mm9 reference genome using BWA-MEM46. Peaks were called using MACS253. Peaks calls from the Foxp3 experiments together to create a union set of peaks. Using this merged peak set, we then identified differential Foxp3 sites using edgeR50.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Supplementary information
Source data
Acknowledgements
We would like to thank T. Hua, N. Tessler, and C. Gordon for mouse colony management, C. O’Connor for assistance in flow cytometry, Y. Dayn for assistance in generating the Foxp3 DSM mutant mice. Z.L. was supported by the National Natural Science Foundation of China (32370937), a NOMIS Fellowship. D.S.L. was supported by the National Research Foundation (NRF) of Korea awards NRF2021R1C1C100679813, NRF2022M3A9D301684812, and NRF2022M3H9A108101113. Y.Z. was supported by the NOMIS Foundation, the Crohn’s and Colitis Foundation, the Sol Goldman Trust, and National Institutes of Health (R01-AI107027, R01-AI1511123, R21-AI154919, and S10-OD023689). J.R.D. was supported by grants from National Institutes of Health (DP5-OD023071 and U01-CA260700). This study was supported by Shanghai Immune Therapy Institute, and was also supported by National Cancer Institute funded Salk Institute Cancer Center Core Facilities (P30-CA014195).
Author contributions
Conceptualization: Z.L., D.S.L., Y.Z. and J.R.D. Methodology: Z.L. and D.S.L. Investigation: Z.L., D.S.L. and Y.L. Resources: Y.Z. and J.R.D. Formal analysis: Z.L., D.S.L. and J.R.D. Data Curation: Z.L. D.S.L. and J.R.D. Supervision: Y.Z. and J.R.D. Funding acquisition: Y.Z. and J.R.D Writing – original draft preparation: Z.L., D.S.L., Y.Z. and J.R.D. Writing – review and editing: Z.L., D.S.L., Y.Z. and J.R.D.
Peer review
Peer review information
Nature Communications thanks Shohei Hori and Chenfu Shi for their contribution to the peer review of this work. A peer review file is available.
Data availability
The sequencing data from the RNA-seq, ChIP-seq, CUT&RUN, Hi-C, and PLAC-seq experiments have been deposited in Gene Expression Omnibus (GEO) with the following accession ID: GSE217147. [https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi]. Source data are provided with this paper.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Zhi Liu, Dong-Sung Lee.
These authors jointly supervised this work: Ye Zheng, Jesse R. Dixon.
Contributor Information
Ye Zheng, Email: yzheng@salk.edu.
Jesse R. Dixon, Email: jedixon@salk.edu
Supplementary information
The online version contains supplementary material available at 10.1038/s41467-023-42647-y.
References
- 1.Lieberman-Aiden E, et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science. 2009;326:289–293. doi: 10.1126/science.1181369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rao SSP, et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014;159:1665–1680. doi: 10.1016/j.cell.2014.11.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Dixon JR, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 2012;485:376–380. doi: 10.1038/nature11082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bonev B, Cavalli G. Organization and function of the 3D genome. Nat. Rev. Genet. 2016;17:661–678. doi: 10.1038/nrg.2016.112. [DOI] [PubMed] [Google Scholar]
- 5.Schmitt AD, Hu M, Ren B. Genome-wide mapping and analysis of chromosome architecture. Nat. Rev. Mol. Cell Biol. 2016;17:743–755. doi: 10.1038/nrm.2016.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dixon JR, Gorkin DU, Ren B. Chromatin domains: the unit of chromosome organization. Mol. Cell. 2016;62:668–680. doi: 10.1016/j.molcel.2016.05.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zheng H, Xie W. The role of 3D genome organization in development and cell differentiation. Nat. Rev. Mol. Cell Biol. 2019;20:535–550. doi: 10.1038/s41580-019-0132-4. [DOI] [PubMed] [Google Scholar]
- 8.Stadhouders R, Filion GJ, Graf T. Transcription factors and 3D genome conformation in cell-fate decisions. Nature. 2019;569:345–354. doi: 10.1038/s41586-019-1182-7. [DOI] [PubMed] [Google Scholar]
- 9.Merkenschlager M, Nora EP. CTCF and cohesin in genome folding and transcriptional gene regulation. Annu. Rev. Genom. Hum. Genet. 2016;17:17–43. doi: 10.1146/annurev-genom-083115-022339. [DOI] [PubMed] [Google Scholar]
- 10.Johanson TM, et al. Transcription-factor-mediated supervision of global genome architecture maintains B cell identity. Nat. Immunol. 2018;19:1257–1264. doi: 10.1038/s41590-018-0234-8. [DOI] [PubMed] [Google Scholar]
- 11.Kim S, Shendure J. Mechanisms of interplay between transcription factors and the 3D genome. Mol. Cell. 2019;76:306–319. doi: 10.1016/j.molcel.2019.08.010. [DOI] [PubMed] [Google Scholar]
- 12.Hu G, et al. Transformation of accessible chromatin and 3D nucleome underlies lineage commitment of early T cells. Immunity. 2018;48:227–242.e8. doi: 10.1016/j.immuni.2018.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang W, et al. TCF-1 promotes chromatin interactions across topologically associating domains in T cell progenitors. Nat. Immunol. 2022;23:1052–1062. doi: 10.1038/s41590-022-01232-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Shan Q, et al. Tcf1-CTCF cooperativity shapes genomic architecture to promote CD8+ T cell homeostasis. Nat. Immunol. 2022;23:1222–1235. doi: 10.1038/s41590-022-01263-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Yui MA, Rothenberg EV. Developmental gene networks: a triathlon on the course to T cell identity. Nat. Rev. Immunol. 2014;14:529–545. doi: 10.1038/nri3702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Owen DL, et al. Thymic regulatory T cells arise via two distinct developmental programs. Nat. Immunol. 2019;20:195–205. doi: 10.1038/s41590-018-0289-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lio C-WJ, Hsieh C-S. A two-step process for thymic regulatory T cell development. Immunity. 2008;28:100–111. doi: 10.1016/j.immuni.2007.11.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Josefowicz SZ, Lu L-F, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 2012;30:531–564. doi: 10.1146/annurev.immunol.25.022106.141623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Sakaguchi S, et al. Regulatory T cells and human disease. Annu. Rev. Immunol. 2020;38:541–566. doi: 10.1146/annurev-immunol-042718-041717. [DOI] [PubMed] [Google Scholar]
- 20.Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061. doi: 10.1126/science.1079490. [DOI] [PubMed] [Google Scholar]
- 21.Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003;4:330–336. doi: 10.1038/ni904. [DOI] [PubMed] [Google Scholar]
- 22.Fontenot JD, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22:329–341. doi: 10.1016/j.immuni.2005.01.016. [DOI] [PubMed] [Google Scholar]
- 23.Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 2007;8:277–284. doi: 10.1038/ni1437. [DOI] [PubMed] [Google Scholar]
- 24.Kwon H-K, Chen H-M, Mathis D, Benoist C. Different molecular complexes that mediate transcriptional induction and repression by FoxP3. Nat. Immunol. 2017;18:1238–1248. doi: 10.1038/ni.3835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Angelin A, et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 2017;25:1282–1293.e7. doi: 10.1016/j.cmet.2016.12.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 2007;8:457–462. doi: 10.1038/ni1455. [DOI] [PubMed] [Google Scholar]
- 27.Van Gool F, et al. A mutation in the transcription factor Foxp3 Drives T Helper 2 Effector function in regulatory T Cells. Immunity. 2019;50:362–377.e6. doi: 10.1016/j.immuni.2018.12.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Rudra D, et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat. Immunol. 2012;13:1010–1019. doi: 10.1038/ni.2402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Samstein RM, et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell. 2012;151:153–166. doi: 10.1016/j.cell.2012.06.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ramirez, R. N., Chowdhary, K., Leon, J., Mathis, D. & Benoist, C. FoxP3 associates with enhancer-promoter loops to regulate Treg-specific gene expression. Sci. Immunol. 7, eabj9836 (2022). [DOI] [PMC free article] [PubMed]
- 31.Bandukwala HS, et al. Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. Immunity. 2011;34:479–491. doi: 10.1016/j.immuni.2011.02.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hill JA, et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity. 2007;27:786–800. doi: 10.1016/j.immuni.2007.09.010. [DOI] [PubMed] [Google Scholar]
- 33.Gavin MA, et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 2007;445:771–775. doi: 10.1038/nature05543. [DOI] [PubMed] [Google Scholar]
- 34.Rao SSP, et al. Cohesin loss eliminates all loop domains. Cell. 2017;171:305–320.e24. doi: 10.1016/j.cell.2017.09.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nora EP, et al. Targeted degradation of CTCF decouples local insulation of chromosome domains from genomic compartmentalization. Cell. 2017;169:930–944.e22. doi: 10.1016/j.cell.2017.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Fang R, et al. Mapping of long-range chromatin interactions by proximity ligation-assisted ChIP-seq. Cell Res. 2016;26:1345–1348. doi: 10.1038/cr.2016.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Gilbert LA, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 2013;154:442–451. doi: 10.1016/j.cell.2013.06.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Leng F, et al. The transcription factor FoxP3 can fold into two dimerization states with divergent implications for regulatory T cell function and immune homeostasis. Immunity. 2022;55:1354–1369.e8. doi: 10.1016/j.immuni.2022.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Weintraub AS, et al. YY1 is a structural regulator of enhancer-promoter loops. Cell. 2017;171:1573–1588.e28. doi: 10.1016/j.cell.2017.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Liston A, et al. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc. Natl. Acad. Sci. USA. 2008;105:11903–11908. doi: 10.1073/pnas.0801506105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Loo C-S, et al. A Genome-wide CRISPR screen reveals a role for the non-canonical nucleosome-remodeling BAF complex in Foxp3 expression and regulatory T cell function. Immunity. 2020;53:143–157.e8. doi: 10.1016/j.immuni.2020.06.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Yang H, Wang H, Jaenisch R. Generating genetically modified mice using CRISPR/Cas-mediated genome engineering. Nat. Protoc. 2014;9:1956–1968. doi: 10.1038/nprot.2014.134. [DOI] [PubMed] [Google Scholar]
- 43.Skene PJ, Henikoff S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. Elife. 2017;6:e21856. doi: 10.7554/eLife.21856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.van der Veeken J, et al. The Transcription Factor Foxp3 shapes regulatory T cell identity by tuning the activity of trans-acting intermediaries. Immunity. 2020;53:971–984.e5. doi: 10.1016/j.immuni.2020.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Liu Z, et al. Glucocorticoid signaling and regulatory T cells cooperate to maintain the hair-follicle stem-cell niche. Nat. Immunol. 2022;23:1086–1097. doi: 10.1038/s41590-022-01244-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv [q-bio.GN] (2013).
- 47.Dixon JR, et al. Integrative detection and analysis of structural variation in cancer genomes. Nat. Genet. 2018;50:1388–1398. doi: 10.1038/s41588-018-0195-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Imakaev M, et al. Iterative correction of Hi-C data reveals hallmarks of chromosome organization. Nat. Methods. 2012;9:999–1003. doi: 10.1038/nmeth.2148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Durand NC, et al. Juicer provides a one-click system for analyzing loop-resolution Hi-C experiments. Cell Syst. 2016;3:95–98. doi: 10.1016/j.cels.2016.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140. doi: 10.1093/bioinformatics/btp616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Heinz S, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell. 2010;38:576–589. doi: 10.1016/j.molcel.2010.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Alexa, A. & Rahnenfuhrer, J. Gene set enrichment analysis with topGO. https://bioconductor.statistik.tudortmund.de/packages/3.3/bioc/vignettes/topGO/inst/doc/topGO.pdf.
- 53.Zhang Y, et al. Model-based analysis of ChIP-Seq (MACS) Genome Biol. 2008;9:R137. doi: 10.1186/gb-2008-9-9-r137. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The sequencing data from the RNA-seq, ChIP-seq, CUT&RUN, Hi-C, and PLAC-seq experiments have been deposited in Gene Expression Omnibus (GEO) with the following accession ID: GSE217147. [https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi]. Source data are provided with this paper.